New Orleans Gets Breakthrough Cancer Treatment Technology

Cancer patients in the southern United States will soon have access to a revolutionary treatment that uses their own cancer cells to guide radiation therapy with unprecedented precision.

Ochsner MD Anderson Cancer Center in New Orleans has installed a groundbreaking machine at Ochsner Baptist that combines PET imaging with radiation delivery in a way never before available in the region. The facility joins only seven other centers worldwide offering biology-guided radiotherapy (BgRT), currently FDA-approved for lung and bone tumors.

The technology works like a biological GPS system. Patients receive an injection of a radiopharmaceutical that cancer cells consume, creating signals from the tumor. The machine uses these signals to determine exactly where and how much radiation to deliver, second by second, tracking the cancer even as it moves with breathing or other bodily functions.

"We are leading a transformative shift in cancer care," said Dr. Troy Scroggins Jr., chair of radiation oncology at Ochsner MD Anderson. The treatment can target multiple tumors in one session while protecting healthy tissue, resulting in fewer side effects for patients.

Traditional radiation therapy struggles with moving targets. This new approach acts like a spotlight following a dancer across a stage, constantly adjusting to keep the radiation focused on cancer cells rather than surrounding healthy tissue.

The Ripple Effect

This advancement extends beyond just better targeting. The technology opens doors for treating metastatic cancer with radiation therapy, not just early-stage disease. That means patients who previously had limited options might now have access to precision treatment.

Ochsner MD Anderson treats more than 40,000 patients annually from all 50 states and 28 countries. Now patients across the Gulf South can access this cutting-edge therapy without traveling across the country or world.

The cancer center's commitment to bringing advanced treatments closer to home reflects a broader shift in healthcare. Patients from Louisiana, Mississippi, and surrounding states will soon benefit from technology previously available only at a handful of elite facilities globally.

The treatment will be available to eligible patients soon, offering hope for more effective cancer care with less collateral damage to the body.